rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2005-1-7
|
pubmed:abstractText |
The purpose of this article is to review the pharmacological treatment of neuropathic trigeminal pain by means of a systematic review. A number of randomized controlled trials and important historical and uncontrolled studies in trigeminal neuralgia and postherpetic neuralgia were identified. Trigeminal neuralgia is a unique neuropathic pain disorder with a specific therapy. It does not respond to the usual drugs used for other neuropathic pains. The drug therapy of trigeminal postherpetic neuralgia is similar to that of other neuropathic trigeminal pain conditions.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
D
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Amines,
http://linkedlifedata.com/resource/pubmed/chemical/Analgesics, Non-Narcotic,
http://linkedlifedata.com/resource/pubmed/chemical/Anticonvulsants,
http://linkedlifedata.com/resource/pubmed/chemical/Antidepressive Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Baclofen,
http://linkedlifedata.com/resource/pubmed/chemical/Carbamazepine,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclohexanecarboxylic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Narcotics,
http://linkedlifedata.com/resource/pubmed/chemical/Phenytoin,
http://linkedlifedata.com/resource/pubmed/chemical/Triazines,
http://linkedlifedata.com/resource/pubmed/chemical/gabapentin,
http://linkedlifedata.com/resource/pubmed/chemical/gamma-Aminobutyric Acid,
http://linkedlifedata.com/resource/pubmed/chemical/lamotrigine
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1064-6655
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
366-73
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:15636022-Amines,
pubmed-meshheading:15636022-Analgesics, Non-Narcotic,
pubmed-meshheading:15636022-Anticonvulsants,
pubmed-meshheading:15636022-Antidepressive Agents,
pubmed-meshheading:15636022-Baclofen,
pubmed-meshheading:15636022-Carbamazepine,
pubmed-meshheading:15636022-Cranial Nerve Injuries,
pubmed-meshheading:15636022-Cyclohexanecarboxylic Acids,
pubmed-meshheading:15636022-Facial Neuralgia,
pubmed-meshheading:15636022-Facial Pain,
pubmed-meshheading:15636022-Herpes Zoster,
pubmed-meshheading:15636022-Humans,
pubmed-meshheading:15636022-Narcotics,
pubmed-meshheading:15636022-Phenytoin,
pubmed-meshheading:15636022-Triazines,
pubmed-meshheading:15636022-Trigeminal Nerve Injuries,
pubmed-meshheading:15636022-Trigeminal Neuralgia,
pubmed-meshheading:15636022-gamma-Aminobutyric Acid
|
pubmed:year |
2004
|
pubmed:articleTitle |
Management issues of neuropathic trigeminal pain from a medical perspective.
|
pubmed:affiliation |
Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
|
pubmed:publicationType |
Journal Article,
Review
|